Structural Determinant of β-Amyloid Formation: From Transmembrane Protein Dimerization to β-Amyloid Aggregates

Carrell, 1997, Conformational disease, Lancet, 350, 134, 10.1016/S0140-6736(97)02073-4

Walker, 2000, The cerebral proteopathies, Neurobiol. Aging, 21, 559, 10.1016/S0197-4580(00)00160-3

Ross, 2004, Protein aggregation and neurodegenerative disease, Nat. Med., 10, S10, 10.1038/nm1066

Virchow, 1989, Cellular pathology. As based upon physiological and pathological histology. Lecture XVI–Atheromatous affection of arteries. 1858, Nutr. Rev., 47, 23, 10.1111/j.1753-4887.1989.tb02747.x

Chiti, 2006, Protein misfolding, functional amyloid, and human disease, Annu. Rev. Biochem., 75, 333, 10.1146/annurev.biochem.75.101304.123901

Lu, 2013, Molecular structure of β-amyloid fibrils in Alzheimer’s disease brain tissue, Cell, 154, 1257, 10.1016/j.cell.2013.08.035

Kollmer, 2019, Cryo-EM structure and polymorphism of Aβ amyloid fibrils purified from Alzheimer’s brain tissue, Nat. Commun., 10, 4760, 10.1038/s41467-019-12683-8

Gremer, 2017, Fibril structure of amyloid-β(1-42) by cryo-electron microscopy, Science, 358, 116, 10.1126/science.aao2825

Haass, 2007, Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer’s amyloid beta-peptide, Nat. Rev. Mol. Cell Biol., 8, 101, 10.1038/nrm2101

Bertram, 2005, The genetic epidemiology of neurodegenerative disease, J. Clin. Investig., 115, 1449, 10.1172/JCI24761

Goto, Y., Noji, M., Nakajima, K., and Yamaguchi, K. (2022). Supersaturation-Dependent Formation of Amyloid Fibrils. Molecules, 27.

Morimoto, 2014, Proteostasis and the aging proteome in health and disease, J. Gerontol. A Biol. Sci. Med. Sci., 69, S33, 10.1093/gerona/glu049

Braak, 1991, Neuropathological stageing of Alzheimer-related changes, Acta Neuropathol., 82, 239, 10.1007/BF00308809

Thal, 2002, Phases of A beta-deposition in the human brain and its relevance for the development of AD, Neurology, 58, 1791, 10.1212/WNL.58.12.1791

Hardy, 2006, Alzheimer’s disease: The amyloid cascade hypothesis: An update and reappraisal, J. Alzheimers. Dis, 9, 151, 10.3233/JAD-2006-9S317

Hardy, 1991, Amyloid deposition as the central event in the aetiology of Alzheimer’s disease, Trends Pharmacol. Sci., 12, 383, 10.1016/0165-6147(91)90609-V

Herrup, 2015, The case for rejecting the amyloid cascade hypothesis, Nat. Neurosci., 18, 794, 10.1038/nn.4017

Tanzi, 2012, The genetics of Alzheimer disease, Cold Spring Harb. Perspect. Med., 2, a006296, 10.1101/cshperspect.a006296

Kang, 1987, The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface receptor, Nature, 325, 733, 10.1038/325733a0

Slunt, 1994, Expression of a ubiquitous, cross-reactive homologue of the mouse beta-amyloid precursor protein (APP), J. Biol. Chem., 269, 2637, 10.1016/S0021-9258(17)41992-2

Tanzi, 1987, Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus, Science, 235, 880, 10.1126/science.2949367

Wasco, 1992, Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid beta protein precursor, Proc. Natl. Acad. Sci. USA, 89, 10758, 10.1073/pnas.89.22.10758

Musa, 2001, Distinct expression patterns of two zebrafish homologues of the human APP gene during embryonic development, Dev. Genes Evol., 211, 563, 10.1007/s00427-001-0189-9

Rosen, 1989, A Drosophila gene encoding a protein resembling the human beta-amyloid protein precursor, Proc. Natl. Acad. Sci. USA, 86, 2478, 10.1073/pnas.86.7.2478

Shariati, 2013, Redundancy and divergence in the amyloid precursor protein family, FEBS Lett., 587, 2036, 10.1016/j.febslet.2013.05.026

Glenner, 1984, Alzheimer’s disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein, Biochem. Biophys. Res. Commun., 120, 885, 10.1016/S0006-291X(84)80190-4

Tanaka, 1988, Three types of amyloid protein precursor mRNA in human brain: Their differential expression in Alzheimer’s disease, Biochem. Biophys. Res. Commun., 157, 472, 10.1016/S0006-291X(88)80273-0

Sprecher, 1993, Molecular cloning of the cDNA for a human amyloid precursor protein homolog: Evidence for a multigene family, Biochemistry, 32, 4481, 10.1021/bi00068a002

Wasco, 1993, Isolation and characterization of APLP2 encoding a homologue of the Alzheimer’s associated amyloid beta protein precursor, Nat. Genet., 5, 95, 10.1038/ng0993-95

Zheng, 2012, Physiological functions of APP family proteins, Cold Spring Harb. Perspect. Med., 2, a006288

Wang, 2004, The X-ray structure of an antiparallel dimer of the human amyloid precursor protein E2 domain, Mol. Cell, 15, 343, 10.1016/j.molcel.2004.06.037

Lee, 2011, The E2 Domains of APP and APLP1 Share a Conserved Mode of Dimerization, Biochemistry, 50, 5453, 10.1021/bi101846x

Roisman, 2019, The crystal structure of amyloid precursor-like protein 2 E2 domain completes the amyloid precursor protein family, FASEB J., 33, 5076, 10.1096/fj.201802315R

Jumper, 2021, Highly accurate protein structure prediction with AlphaFold, Nature, 596, 583, 10.1038/s41586-021-03819-2

Dahms, 2010, Structure and biochemical analysis of the heparin-induced E1 dimer of the amyloid precursor protein, Proc. Natl. Acad. Sci. USA, 107, 5381, 10.1073/pnas.0911326107

Hynes, 1990, X-ray crystal structure of the protease inhibitor domain of Alzheimer’s amyloid beta-protein precursor, Biochemistry, 29, 10018, 10.1021/bi00495a002

Beher, 1996, Regulation of Amyloid Protein Precursor (APP) Binding to Collagen and Mapping of the Binding Sites on APP and Collagen Type I (∗), J. Biol. Chem., 271, 1613, 10.1074/jbc.271.3.1613

Schubert, 1989, Characterization of an amyloid beta precursor protein that binds heparin and contains tyrosine sulfate, Proc. Natl. Acad. Sci. USA, 86, 2066, 10.1073/pnas.86.6.2066

Small, 1994, A heparin-binding domain in the amyloid protein precursor of Alzheimer’s disease is involved in the regulation of neurite outgrowth, J. Neurosci., 14, 2117, 10.1523/JNEUROSCI.14-04-02117.1994

Hoefgen, 2014, Heparin induced dimerization of APP is primarily mediated by E1 and regulated by its acidic domain, J. Struct. Biol., 187, 30, 10.1016/j.jsb.2014.05.006

Soba, 2005, Homo- and heterodimerization of APP family members promotes intercellular adhesion, EMBO J., 24, 3624, 10.1038/sj.emboj.7600824

Bush, 1993, A novel zinc(II) binding site modulates the function of the beta A4 amyloid protein precursor of Alzheimer’s disease, J. Biol. Chem., 268, 16109, 10.1016/S0021-9258(19)85394-2

Multhaup, 1996, The amyloid precursor protein of Alzheimer’s disease in the reduction of copper(II) to copper(I), Science, 271, 1406, 10.1126/science.271.5254.1406

Mayer, 2014, Novel zinc-binding site in the E2 domain regulates amyloid precursor-like protein 1 (APLP1) oligomerization, J. Biol. Chem., 289, 19019, 10.1074/jbc.M114.570382

Dienemann, 2015, Mutants of metal binding site M1 in APP E2 show metal specific differences in binding of heparin but not of sorLA, Biochemistry, 54, 2490, 10.1021/acs.biochem.5b00111

Dahms, 2012, Metal binding dictates conformation and function of the amyloid precursor protein (APP) E2 domain, J. Mol. Biol., 416, 438, 10.1016/j.jmb.2011.12.057

Noda, 2013, Copper enhances APP dimerization and promotes Aβ production, Neurosci. Lett., 547, 10, 10.1016/j.neulet.2013.04.057

Jen, 1997, Cell-specific expression of beta-amyloid precursor protein isoform mRNAs and proteins in neurons and astrocytes, Mol. Brain Res., 47, 147, 10.1016/S0169-328X(97)00045-4

Mahdi, 1995, Protease nexin-2/amyloid beta-protein precursor inhibits factor Xa in the prothrombinase complex, J. Biol. Chem., 270, 23468, 10.1074/jbc.270.40.23468

Scheinfeld, 2002, Processing of beta-amyloid precursor-like protein-1 and -2 by gamma-secretase regulates transcription, J. Biol. Chem., 277, 44195, 10.1074/jbc.M208110200

Beckett, 2012, Nuclear signalling by membrane protein intracellular domains: The AICD enigma, Cell Signal., 24, 402, 10.1016/j.cellsig.2011.10.007

Checler, 2012, The physiology of the beta-amyloid precursor protein intracellular domain AICD, J. Neurochem., 120, 109, 10.1111/j.1471-4159.2011.07475.x

Cao, 2001, A transcriptively active complex of APP with Fe65 and histone acetyltransferase Tip60, Science, 293, 115, 10.1126/science.1058783

Cao, 2004, Dissection of amyloid-beta precursor protein-dependent transcriptional transactivation, J. Biol. Chem, 279, 24601, 10.1074/jbc.M402248200

Hebert, 2006, Regulated intramembrane proteolysis of amyloid precursor protein and regulation of expression of putative target genes, EMBO Rep., 7, 739, 10.1038/sj.embor.7400704

Opsomer, R., Contino, S., Perrin, F., Gualdani, R., Tasiaux, B., Doyen, P., Vergouts, M., Vrancx, C., Doshina, A., and Pierrot, N. (2020). Amyloid Precursor Protein (APP) Controls the Expression of the Transcriptional Activator Neuronal PAS Domain Protein 4 (NPAS4) and Synaptic GABA Release. eNeuro, 7.

Sisodia, 1990, Evidence that beta-amyloid protein in Alzheimer’s disease is not derived by normal processing, Science, 248, 492, 10.1126/science.1691865

Esch, 1990, Cleavage of amyloid beta peptide during constitutive processing of its precursor, Science, 248, 1122, 10.1126/science.2111583

Eggert, 2004, The proteolytic processing of the amyloid precursor protein gene family members APLP-1 and APLP-2 involves alpha-, beta-, gamma-, and epsilon-like cleavages: Modulation of APLP-1 processing by n-glycosylation, J. Biol. Chem., 279, 18146, 10.1074/jbc.M311601200

Kuhn, 2010, ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons, Embo J., 29, 3020, 10.1038/emboj.2010.167

Jacobsen, 2010, Insulin-like Growth Factor-1 (IGF-1)-induced Processing of Amyloid-β Precursor Protein (APP) and APP-like Protein 2 Is Mediated by Different Metalloproteinases*, J. Biol. Chem., 285, 10223, 10.1074/jbc.M109.038224

Sisodia, 1992, Beta-amyloid precursor protein cleavage by a membrane-bound protease, Proc. Natl. Acad. Sci. USA, 89, 6075, 10.1073/pnas.89.13.6075

Dislich, 2012, The Membrane-Bound Aspartyl Protease BACE1: Molecular and Functional Properties in Alzheimer’s Disease and Beyond, Front Physiol., 3, 8, 10.3389/fphys.2012.00008

Deng, 2013, Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis, Eur. J. Neurosci., 37, 1962, 10.1111/ejn.12235

Zhang, 2017, BACE1 Cleavage Site Selection Critical for Amyloidogenesis and Alzheimer’s Pathogenesis, J. Neurosci., 37, 6915, 10.1523/JNEUROSCI.0340-17.2017

Kimura, 2016, Alternative Selection of β-Site APP-Cleaving Enzyme 1 (BACE1) Cleavage Sites in Amyloid β-Protein Precursor (APP) Harboring Protective and Pathogenic Mutations within the Aβ Sequence, J. Biol. Chem., 291, 24041, 10.1074/jbc.M116.744722

Weidemann, 2002, A novel epsilon-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processing, Biochemistry, 41, 2825, 10.1021/bi015794o

Takami, 2009, γ-Secretase: Successive Tripeptide and Tetrapeptide Release from the Transmembrane Domain of β-Carboxyl Terminal Fragment, J. Neurosci., 29, 13042, 10.1523/JNEUROSCI.2362-09.2009

Bolduc, 2016, The amyloid-beta forming tripeptide cleavage mechanism of γ-secretase, Elife, 5, e17578, 10.7554/eLife.17578

Hogl, S., Kuhn, P.H., Colombo, A., and Lichtenthaler, S.F. (2011). Determination of the proteolytic cleavage sites of the amyloid precursor-like protein 2 by the proteases ADAM10, BACE1 and γ-secretase. PLoS ONE, 6.

Liu, 2004, Residues 17-20 and 30-35 of beta-amyloid play critical roles in aggregation, J. Neurosci. Res., 75, 162, 10.1002/jnr.10859

Hu, 2017, β-Sheet Structure within the Extracellular Domain of C99 Regulates Amyloidogenic Processing, Sci. Rep., 7, 17159, 10.1038/s41598-017-17144-0

Söldner, C.A., Sticht, H., and Horn, A.H.C. (2017). Role of the N-terminus for the stability of an amyloid-β fibril with three-fold symmetry. PLoS ONE, 12.

Scheuermann, 2001, Homodimerization of amyloid precursor protein and its implication in the amyloidogenic pathway of Alzheimer’s disease, J. Biol. Chem., 276, 33923, 10.1074/jbc.M105410200

Tyteca, 2012, Structural features of the KPI domain control APP dimerization, trafficking, and processing, FASEB J., 26, 855, 10.1096/fj.11-190207

Tasiaux, 2008, Amyloidogenic Processing but Not Amyloid Precursor Protein (APP) Intracellular C-terminal Domain Production Requires a Precisely Oriented APP Dimer Assembled by Transmembrane GXXXG Motifs, J. Biol. Chem., 283, 7733, 10.1074/jbc.M707142200

Munter, 2007, GxxxG motifs within the amyloid precursor protein transmembrane sequence are critical for the etiology of Abeta42, EMBO J., 26, 1702, 10.1038/sj.emboj.7601616

Adams, 1996, Improved prediction for the structure of the dimeric transmembrane domain of glycophorin A obtained through global searching, Proteins, 26, 257, 10.1002/(SICI)1097-0134(199611)26:3<257::AID-PROT2>3.0.CO;2-B

Lemmon, 1994, A dimerization motif for transmembrane alpha-helices, Nat. Struct. Biol., 1, 157, 10.1038/nsb0394-157

Russ, 2000, The GxxxG motif: A framework for transmembrane helix-helix association, J. Mol. Biol, 296, 911, 10.1006/jmbi.1999.3489

Lemmon, 1992, Sequence specificity in the dimerization of transmembrane alpha-helices, Biochemistry, 31, 12719, 10.1021/bi00166a002

Teese, 2015, Role of GxxxG Motifs in Transmembrane Domain Interactions, Biochemistry, 54, 5125, 10.1021/acs.biochem.5b00495

Kirrbach, 2013, Self-interaction of transmembrane helices representing pre-clusters from the human single-span membrane proteins, Bioinformatics, 29, 1623, 10.1093/bioinformatics/btt247

Hendriks, 1992, Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene, Nat. Genet., 1, 218, 10.1038/ng0692-218

Harrison, 2010, Conservation of a glycine-rich region in the prion protein is required for uptake of prion infectivity, J. Biol. Chem., 285, 20213, 10.1074/jbc.M109.093310

Tang, 2014, Conformational changes induced by the A21G Flemish mutation in the amyloid precursor protein lead to increased Aβ production, Structure, 22, 387, 10.1016/j.str.2013.12.012

Beel, 2008, Structural studies of the transmembrane C-terminal domain of the amyloid precursor protein (APP): Does APP function as a cholesterol sensor?, Biochemistry, 47, 9428, 10.1021/bi800993c

Nadezhdin, 2012, Dimeric structure of transmembrane domain of amyloid precursor protein in micellar environment, FEBS Lett., 586, 1687, 10.1016/j.febslet.2012.04.062

Perrin, 2020, Dimeric Transmembrane Orientations of APP/C99 Regulate γ-Secretase Processing Line Impacting Signaling and Oligomerization, iScience, 23, 101887, 10.1016/j.isci.2020.101887

Decock, 2015, Analysis by a highly sensitive split luciferase assay of the regions involved in APP dimerization and its impact on processing, FEBS Open. Biol., 5, 763, 10.1016/j.fob.2015.09.002

Decock, 2016, Glycines from the APP GXXXG/GXXXA Transmembrane Motifs Promote Formation of Pathogenic Abeta Oligomers in Cells, Front. Aging Neurosci., 8, 107, 10.3389/fnagi.2016.00107

Higashide, 2017, Alanine substitutions in the GXXXG motif alter C99 cleavage by gamma-secretase but not its dimerization, J. Neurochem., 140, 955, 10.1111/jnc.13942

Munter, 2010, Aberrant amyloid precursor protein (APP) processing in hereditary forms of Alzheimer disease caused by APP familial Alzheimer disease mutations can be rescued by mutations in the APP GxxxG motif, J. Biol. Chem, 285, 21636, 10.1074/jbc.M109.088005

Sagi, 2011, Substrate sequence influences gamma-secretase modulator activity, role of the transmembrane domain of the amyloid precursor protein, J. Biol. Chem., 286, 39794, 10.1074/jbc.M111.277228

Sato, 2009, A helix-to-coil transition at the epsilon-cut site in the transmembrane dimer of the amyloid precursor protein is required for proteolysis, Proc. Natl. Acad. Sci. USA, 106, 1421, 10.1073/pnas.0812261106

So, 2013, Comparable dimerization found in wildtype and familial Alzheimer’s disease amyloid precursor protein mutants, Am. J. Neurodegener. Dis., 2, 15

Richter, 2010, Amyloid beta 42 peptide (Abeta42)-lowering compounds directly bind to Abeta and interfere with amyloid precursor protein (APP) transmembrane dimerization, Proc. Natl. Acad. Sci. USA, 107, 14597, 10.1073/pnas.1003026107

Eggert, 2009, Induced dimerization of the amyloid precursor protein leads to decreased amyloid-beta protein production, J. Biol. Chem., 284, 28943, 10.1074/jbc.M109.038646

Zhou, R., Yang, G., Guo, X., Zhou, Q., Lei, J., and Shi, Y. (2019). Recognition of the amyloid precursor protein by human γ-secretase. Science, 363.

Eggert, 2018, Dimerization leads to changes in APP (amyloid precursor protein) trafficking mediated by LRP1 and SorLA, Cell. Mol. Life Sci., 75, 301, 10.1007/s00018-017-2625-7

Wong, C.-O. (2020). Endosomal-Lysosomal Processing of Neurodegeneration-Associated Proteins in Astrocytes. Int. J. Mol. Sci., 21.

Edbauer, 2003, Reconstitution of gamma-secretase activity, Nat. Cell Biol., 5, 486, 10.1038/ncb960

Wolfe, 1999, Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity, Nature, 398, 513, 10.1038/19077

Zhang, 2013, Biological function of Presenilin and its role in AD pathogenesis, Transl. Neurodegener., 2, 15, 10.1186/2047-9158-2-15

2007, Loss-of-function presenilin mutations in Alzheimer disease. Talking Point on the role of presenilin mutations in Alzheimer disease, EMBO Rep., 8, 141, 10.1038/sj.embor.7400897

Sannerud, 2016, Restricted Location of PSEN2/γ-Secretase Determines Substrate Specificity and Generates an Intracellular Aβ Pool, Cell, 166, 193, 10.1016/j.cell.2016.05.020

Bentahir, 2006, Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms, J. Neurochem., 96, 732, 10.1111/j.1471-4159.2005.03578.x

Vrancx, 2021, Mechanism of Cellular Formation and In Vivo Seeding Effects of Hexameric beta-Amyloid Assemblies, Mol. Neurobiol., 58, 6647, 10.1007/s12035-021-02567-8

Ye, 2014, Snapin-mediated BACE1 retrograde transport is essential for its degradation in lysosomes and regulation of APP processing in neurons, Cell Rep., 6, 24, 10.1016/j.celrep.2013.12.008

Huse, 2000, Maturation and endosomal targeting of beta-site amyloid precursor protein-cleaving enzyme. The Alzheimer’s disease beta-secretase, J. Biol. Chem., 275, 33729, 10.1074/jbc.M004175200

Pastorino, 2002, The carboxyl-terminus of BACE contains a sorting signal that regulates BACE trafficking but not the formation of total A(beta), Mol. Cell Neurosci., 19, 175, 10.1006/mcne.2001.1065

Das, 2013, Activity-induced convergence of APP and BACE-1 in acidic microdomains via an endocytosis-dependent pathway, Neuron, 79, 447, 10.1016/j.neuron.2013.05.035

Marinangeli, 2015, Presenilin transmembrane domain 8 conserved AXXXAXXXG motifs are required for the activity of the gamma-secretase complex, J. Biol. Chem., 290, 7169, 10.1074/jbc.M114.601286

Lee, 2004, A conserved GXXXG motif in APH-1 is critical for assembly and activity of the gamma-secretase complex, J. Biol. Chem., 279, 4144, 10.1074/jbc.M309745200

Liu, 2021, Hydrophilic loop 1 of Presenilin-1 and the APP GxxxG transmembrane motif regulate gamma-secretase function in generating Alzheimer-causing Abeta peptides, J. Biol. Chem., 296, 100393, 10.1016/j.jbc.2021.100393

Alzheimer, 1911, über eigenartige Krankheitsfälle des späteren Alters, Z. Für Die Gesamte Neurol. Und Psychiatr., 4, 356, 10.1007/BF02866241

Foley, 2010, Lipids in Alzheimer’s disease: A century-old story, Biochim. Biophys. Acta, 1801, 750, 10.1016/j.bbalip.2010.05.004

Gursky, O. (2015). Lipids in Amyloid-β Processing, Aggregation, and Toxicity. Lipids in Protein Misfolding, Springer International Publishing.

Grimm, 2017, APP Function and Lipids: A Bidirectional Link, Front. Mol. Neurosci., 10, 63, 10.3389/fnmol.2017.00063

Kivipelto, 2001, Midlife vascular risk factors and Alzheimer’s disease in later life: Longitudinal, population based study, BMJ, 322, 1447, 10.1136/bmj.322.7300.1447

Kuo, 1998, Elevated low-density lipoprotein in Alzheimer’s disease correlates with brain abeta 1–42 levels, Biochem. Biophys. Res. Commun., 252, 711, 10.1006/bbrc.1998.9652

Sáiz-Vazquez, O., Puente-Martínez, A., Ubillos-Landa, S., Pacheco-Bonrostro, J., and Santabárbara, J. (2020). Cholesterol and Alzheimer’s Disease Risk: A Meta-Meta-Analysis. Brain Sci., 10.

Corder, 1993, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families, Science, 261, 921, 10.1126/science.8346443

Saunders, 1993, Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer’s disease, Neurology, 43, 1467, 10.1212/WNL.43.8.1467

Strittmatter, 1993, Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease, Proc. Natl. Acad. Sci. USA, 90, 1977, 10.1073/pnas.90.5.1977

Bodovitz, 1996, Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein, J. Biol. Chem., 271, 4436, 10.1074/jbc.271.8.4436

Simons, 1998, Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons, Proc. Natl. Acad. Sci. USA, 95, 6460, 10.1073/pnas.95.11.6460

Ghribi, 2006, High cholesterol content in neurons increases BACE, beta-amyloid, and phosphorylated tau levels in rabbit hippocampus, Exp. Neurol., 200, 460, 10.1016/j.expneurol.2006.03.019

Cordy, 2003, Exclusively targeting β-secretase to lipid rafts by GPI-anchor addition up-regulates β-site processing of the amyloid precursor protein, Proc. Natl. Acad. Sci. USA, 100, 11735, 10.1073/pnas.1635130100

Song, 2014, Cholesterol as a co-solvent and a ligand for membrane proteins, Protein Sci., 23, 1, 10.1002/pro.2385

Barrett, 2012, The amyloid precursor protein has a flexible transmembrane domain and binds cholesterol, Science, 336, 1168, 10.1126/science.1219988

Song, 2013, Competition between homodimerization and cholesterol binding to the C99 domain of the amyloid precursor protein, Biochemistry, 52, 5051, 10.1021/bi400735x

Langness, 2021, Cholesterol-lowering drugs reduce APP processing to Aβ by inducing APP dimerization, Mol. Biol. Cell, 32, 247, 10.1091/mbc.E20-05-0345

Dominguez, 2016, Impact of membrane lipid composition on the structure and stability of the transmembrane domain of amyloid precursor protein, Proc. Natl. Acad. Sci. USA, 113, E5281, 10.1073/pnas.1606482113

Li, 2022, Effect of Cholesterol on C99 Dimerization: Revealed by Molecular Dynamics Simulations, Front. Mol. Biosci., 9, 872385, 10.3389/fmolb.2022.872385

Sun, 2017, Dimerization and Structural Stability of Amyloid Precursor Proteins Affected by the Membrane Microenvironments, J. Chem. Inf. Modeling, 57, 1375, 10.1021/acs.jcim.7b00196

Miyashita, 2009, Transmembrane structures of amyloid precursor protein dimer predicted by replica-exchange molecular dynamics simulations, J. Am. Chem. Soc., 131, 3438, 10.1021/ja809227c

Gorman, P.M., Kim, S., Guo, M., Melnyk, R.A., McLaurin, J., Fraser, P.E., Bowie, J.U., and Chakrabartty, A. (2008). Dimerization of the transmembrane domain of amyloid precursor proteins and familial Alzheimer’s disease mutants. BMC Neurosci., 9.

Yan, 2017, Dimerization of the transmembrane domain of amyloid precursor protein is determined by residues around the γ-secretase cleavage sites, J. Biol. Chem., 292, 15826, 10.1074/jbc.M117.789669

Herring, 2016, Amyloid-beta dimers in the absence of plaque pathology impair learning and synaptic plasticity, Brain, 139, 509, 10.1093/brain/awv355

Shankar, 2007, Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway, J. Neurosci., 27, 2866, 10.1523/JNEUROSCI.4970-06.2007

Townsend, 2006, Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: A potent role for trimers, J. Physiol., 572, 477, 10.1113/jphysiol.2005.103754

Barykin, 2017, Amyloid beta Modification: A Key to the Sporadic Alzheimer’s Disease?, Front. Genet., 8, 58, 10.3389/fgene.2017.00058

Kummer, 2014, Truncated and modified amyloid-beta species, Alzheimers Res., 6, 28, 10.1186/alzrt258

Domingo, 2021, N-Terminally Truncated and Pyroglutamate-Modified Abeta Forms Are Measurable in Human Cerebrospinal Fluid and Are Potential Markers of Disease Progression in Alzheimer’s Disease, Front. Neurosci., 15, 708119, 10.3389/fnins.2021.708119

Kumar, 2011, Extracellular phosphorylation of the amyloid beta-peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer’s disease, EMBO J., 30, 2255, 10.1038/emboj.2011.138

Kumar, 2016, Phosphorylation of the amyloid beta-peptide at Ser26 stabilizes oligomeric assembly and increases neurotoxicity, Acta Neuropathol., 131, 525, 10.1007/s00401-016-1546-0

Nirmalraj, 2020, Complete aggregation pathway of amyloid beta (1–40) and (1–42) resolved on an atomically clean interface, Sci. Adv., 6, eaaz6014, 10.1126/sciadv.aaz6014

Almeida, Z.L., and Brito, R.M.M. (2020). Structure and Aggregation Mechanisms in Amyloids. Molecules, 25.

Vadukul, 2021, An evaluation of the self-assembly enhancing properties of cell-derived hexameric amyloid-beta, Sci. Rep., 11, 11570, 10.1038/s41598-021-90680-y

Sato, 2006, Inhibitors of amyloid toxicity based on beta-sheet packing of Abeta40 and Abeta42, Biochemistry, 45, 5503, 10.1021/bi052485f

Misra, 2016, Rapid alpha-oligomer formation mediated by the A beta C terminus initiates an amyloid assembly pathway, Nat. Commun., 7, 12419, 10.1038/ncomms12419

Beel, 2010, Direct binding of cholesterol to the amyloid precursor protein: An important interaction in lipid-Alzheimer’s disease relationships?, Biochim. Biophys. Acta, 1801, 975, 10.1016/j.bbalip.2010.03.008

Miller, 2011, Synergistic interactions between repeats in tau protein and Abeta amyloids may be responsible for accelerated aggregation via polymorphic states, Biochemistry, 50, 5172, 10.1021/bi200400u

Liu, 2013, Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy, Nat. Rev. Neurol., 9, 106, 10.1038/nrneurol.2012.263

Umeda, 2012, Hypercholesterolemia accelerates intraneuronal accumulation of Aβ oligomers resulting in memory impairment in Alzheimer’s disease model mice, Life Sci., 91, 1169, 10.1016/j.lfs.2011.12.022

Lazar, 2013, Time-of-flight secondary ion mass spectrometry (TOF-SIMS) imaging reveals cholesterol overload in the cerebral cortex of Alzheimer disease patients, Acta Neuropathol., 125, 133, 10.1007/s00401-012-1041-1

Gille, 2021, Recent Advances in Studying Age-Associated Lipids Alterations and Dietary Interventions in Mammals, Front. Aging, 2, 773795, 10.3389/fragi.2021.773795